No longer operating.
VintaBio has closed or wound down its CDMO business. It is left out of search results and rankings, and this profile is kept as a record.
VintaBio
Philadelphia, PA
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: VintaBio
- Signal Score
- 59.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Philadelphia, PA
- Modalities
- AAV, Lentiviral
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About VintaBio
Closed. VintaBio stopped operating as a CDMO when it made an Assignment for the Benefit of Creditors (a state-law wind-down) on October 27, 2026. The assignee, Development Specialists, Inc. (DSI), is taking bids until December 15, 2026 for its 22,500 sq ft cGMP viral-vector facility in Philadelphia (4050 S. 26th Street), its equipment and its IP (VintaCells, VintaProcess). Do not plan new work with VintaBio; a buyer of the facility may operate it under another name. Before the ABC it was a Philadelphia AAV and lentiviral vector CDMO founded in 2020. Source: Business Wire, November 3, 2026, https://www.businesswire.com/news/home/20261103879825/en/
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Sites: Philadelphia, PA
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About VintaBio
What is VintaBio's CDMO Signal Score?
VintaBio has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating VintaBio for a manufacturing program?
Use the free AI matchmaker to compare VintaBio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Compare VintaBio with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.